E. Res

发表

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

I. Boukovinas, G. Aravantinos, A. Psyrri, 2020, ESMO Open.

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

K. Syrigos, V. Georgoulias, H. Gogas, 2021, Cancer Immunology, Immunotherapy.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

A. Charchanti, H. Gogas, G. Aravantinos, 2022, Cancers.

Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer

G. Fountzilas, D. Pectasides, A. Batistatou, 2021, AntiCancer Research.

Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment

K. Syrigos, K. Papadopoulou, G. Fountzilas, 2019, Cancer Genomics & Proteomics.

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial

M. Dimopoulos, G. Lazaridis, A. Psyrri, 2020, British Journal of Cancer.

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

P. Papantoniou, G. Aravantinos, G. Fountzilas, 2021, Lung Cancer.

Relapsed and De Novo Metastatic HER2‐positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

E. Giannoulatou, G. Lazaridis, K. Papadopoulou, 2019, Clinical breast cancer.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

G. Fountzilas, G. Mountzios, H. Linardou, 2021, Cancers.

Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy

C. Stefanadis, D. Tousoulis, S. Kyvelou, 2018, OncoTargets and therapy.

Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens

K. Pavlakis, K. Papadopoulou, G. Fountzilas, 2021, Cancer research and treatment.

Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy

C. Stefanadis, D. Tousoulis, S. Kyvelou, 2018 .